Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025
Applied Therapeutics Inc. (NASDAQ: APLT) is back on traders’ radar today, with its penny stock surging on enormous volume despite intense regulatory uncertainty and a stretched balance sheet. On November 17, 2025, APLT is trading like a biotech rollercoaster: pre‑market gains, intraday spikes of 30–70%, and tens of millions of shares changing hands as investors reassess the company’s prospects after last week’s Q3 update and fresh analyst commentary. Benzinga+2Benzinga+2 Below is a detailed look at everything that matters about Applied Therapeutics today, plus the context behind the move. Key Takeaways 1. What Happened to APLT Today? Pre‑market and intraday action
